# Omega-3 Dry Eye Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/omega-3-dry-eye-meta-analysis-evidence-review
Category: evidence-review
Summary: Omega-3 Dry Eye Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed bio
Last reviewed: 2026-05-27
Reviewed by: Migaku Evidence Review
# Omega-3 Dry Eye Meta-analysis: What the Evidence Says

## Quick Answer

Omega-3 Dry Eye Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 observational study, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Potential ocular health benefit of short-term omega-3 fatty acids supplementation on the ocular tear film: An observational study | observational study | 3 | 2026-05-12 | 10.1097/MD.0000000000046566 |
| Dry Eye Disease: From Mechanisms to Management and Future Directions | narrative review | 3 | 2026-03-26 | 10.3390/jcm15072535 |

## What The Sources Report

- Dry eye involves instability of the tear film, increased osmolarity, and inflammation of the ocular surface. [Almutairi Meznah S. (2026); evidence level 3]
- When fish consume phytoplankton that feed on microalgae, they accumulate omega-3 fatty acids in their tissues.Omega-3 fatty acids serve as components of the phospholipids that make up cell membranes.DHA is found in high quantities in the brain and retina. [Almutairi Meznah S. (2026); evidence level 3]
- It is also believed that the risk increases with age but there are more and more cases of the disease among 18-50-year-old age groups because of commonly worn contact lenses and worldwide-used electronic devices like smartphones or computers. [Pniakowska Zofia (2026); evidence level 3]
- This process is accompanied by symptoms reported by patients, and its development is associated with tear film instability, increased osmolarity, inflammatory response, and damage to the barrier of the ocular surface. [Pniakowska Zofia (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For omega-3 dry eye meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Almutairi Meznah S. (2026). Potential ocular health benefit of short-term omega-3 fatty acids supplementation on the ocular tear film: An observational study. DOI: 10.1097/MD.0000000000046566. PMCID: PMC12688933. PMID: 41367008. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12688933/
- Pniakowska Zofia (2026). Dry Eye Disease: From Mechanisms to Management and Future Directions. DOI: 10.3390/jcm15072535. PMCID: PMC13073282. PMID: 41976835. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13073282/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.